₩1,014,000.00
1.40% day before yesterday
Korea, Oct 02, 08:09 am CET
ISIN
KR7207940008
Symbol
207940
Index

SAMSUNG BIOLOGICS Target price 2025 - Analyst rating & recommendation

SAMSUNG BIOLOGICS Classifications & Recommendation:

Buy
97%
Hold
3%

SAMSUNG BIOLOGICS Price Target

Target Price ₩1,346,400.00
Price ₩1,000,000.00
Potential
Number of Estimates 29
29 Analysts have issued a price target SAMSUNG BIOLOGICS 2026 . The average SAMSUNG BIOLOGICS target price is ₩1,346,400.00. This is higher than the current stock price. The highest price target is
₩1,680,000.00 68.00%
register free of charge
, the lowest is
₩1,161,500.00 16.15%
register free of charge
.
A rating was issued by 31 analysts: 30 Analysts recommend SAMSUNG BIOLOGICS to buy, 1 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the SAMSUNG BIOLOGICS stock has an average upside potential 2026 of . Most analysts recommend the SAMSUNG BIOLOGICS stock at Purchase.

Sales and Margin forecast 2025, 2026 & 2027

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Revenue Billion ₩ 4,547.32 5,753.86
23.08% 26.53%
EBITDA Margin 30.05% 43.84%
3.11% 45.91%
Net Margin 23.82% 25.85%
2.62% 8.51%

29 Analysts have issued a sales forecast SAMSUNG BIOLOGICS 2025 . The average SAMSUNG BIOLOGICS sales estimate is

₩5.8t
Unlock
. This is
14.35% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
₩6.3t 25.56%
Unlock
, the lowest is
₩4.4t 12.47%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2024 ₩4.5t 23.08%
2025
₩5.8t 26.53%
Unlock
2026
₩6.7t 16.36%
Unlock
2027
₩7.7t 14.79%
Unlock

28 Analysts have issued an SAMSUNG BIOLOGICS EBITDA forecast 2025. The average SAMSUNG BIOLOGICS EBITDA estimate is

₩2.5t
Unlock
. This is
50.42% higher
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
₩3.1t 87.27%
Unlock
, the lowest is
₩1.9t 11.43%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2024 ₩1.4t 19.26%
2025
₩2.5t 84.62%
Unlock
2026
₩2.9t 13.97%
Unlock
2027
₩3.2t 11.74%
Unlock

EBITDA Margin

2024 30.05% 3.11%
2025
43.84% 45.91%
Unlock
2026
42.94% 2.05%
Unlock
2027
41.80% 2.65%
Unlock

29 SAMSUNG BIOLOGICS Analysts have issued a net profit forecast 2025. The average SAMSUNG BIOLOGICS net profit estimate is

₩1.5t
Unlock
. This is
15.65% higher
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
₩1.8t 38.76%
Unlock
, the lowest is
₩1.3t 0.10%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2024 ₩1.1t 26.31%
2025
₩1.5t 37.28%
Unlock
2026
₩1.8t 18.09%
Unlock
2027
₩2.0t 15.27%
Unlock

Net Margin

2024 23.82% 2.62%
2025
25.85% 8.51%
Unlock
2026
26.23% 1.47%
Unlock
2027
26.34% 0.42%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 & 2027

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Earnings Per Share 15,220.67 20,895.66
26.31% 37.28%
P/E 47.86
EV/Sales 12.45

29 Analysts have issued a SAMSUNG BIOLOGICS forecast for earnings per share. The average SAMSUNG BIOLOGICS EPS is

₩20,895.66
Unlock
. This is
15.66% higher
Unlock
than earnings per share in the financial year 2024. The highest EPS forecast is
₩25,070.69 38.77%
Unlock
, the lowest is
₩18,085.90 0.10%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2024 ₩15,220.67 26.31%
2025
₩20,895.66 37.28%
Unlock
2026
₩24,675.43 18.09%
Unlock
2027
₩28,443.38 15.27%
Unlock

P/E ratio

Current 55.35 18.89%
2025
47.86 13.53%
Unlock
2026
40.53 15.32%
Unlock
2027
35.16 13.25%
Unlock

Based on analysts' sales estimates for 2025, the SAMSUNG BIOLOGICS stock is valued at an EV/Sales of

12.45
Unlock
and an P/S ratio of
12.48
Unlock
.

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 14.23 14.79%
2025
12.45 12.53%
Unlock
2026
10.70 14.06%
Unlock
2027
9.32 12.88%
Unlock

P/S ratio

Current 14.27 14.35%
2025
12.48 12.55%
Unlock
2026
10.73 14.06%
Unlock
2027
9.34 12.88%
Unlock

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today